$JXN
Jackson Financial Inc. Stock $jxn

$jxn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000182299323000009 Filed on March 01, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$9.863B	-$381.0M	$14.55B
YoY Change	129.32%	-123.29%	64.46%
Cost Of Revenue			$2.290B
YoY Change			150.82%
Gross Profit			$12.26B
YoY Change			54.52%
Gross Profit Margin			84.26%
Selling, General & Admin	$1.022B	$997.0M	$3.922B
YoY Change	3.02%	-5.84%	-4.78%
% of Gross Profit			31.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.226B		-$1.743B
YoY Change	40766.67%		-15945.45%
% of Gross Profit			-14.22%
Operating Expenses	$1.262B	$532.0M	$7.327B
YoY Change	-33.4%	-37.89%	53.8%
Operating Profit			$4.934B
YoY Change			55.6%
Interest Expense	$43.00M	-$40.00M	$113.0M
YoY Change	115.0%	122.22%	205.41%
% of Operating Profit			2.29%
Other Income/Expense, Net	-$36.00M	-$106.0M	$34.00M
YoY Change	-250.0%	709.16%	-69.37%
Pretax Income	$7.734B	-$953.0M	$7.111B
YoY Change	224.14%	-227.36%	75.71%
Income Tax	$1.505B	-$235.0M	$1.371B
% Of Pretax Income	19.46%		19.28%
Net Earnings	$6.186B	-$710.0M	$5.697B
YoY Change	205.48%	-221.31%	78.98%
Net Earnings / Revenue	62.72%		39.15%
Basic Earnings Per Share	$72.34	-$8.48	$66.62
Diluted Earnings Per Share	$69.75	-$8.48	$64.23
COMMON SHARES
Basic Shares Outstanding	82.28M shares	83.04M shares	85.51M shares
Diluted Shares Outstanding	82.65M shares		88.69M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.779B	$4.298B	$4.298B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$65.83B	$64.68B	$64.68B
YoY Change	-3.78%	-11.17%	-11.17%
Other Assets	$755.0M	$385.0M	$385.0M
YoY Change	-43.78%	-59.64%	-59.64%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$315.0B	$311.1B	$311.1B
YoY Change	-10.68%	-17.16%	-17.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$545.0M	$689.0M	$689.0M
YoY Change	3.81%	-24.53%	-24.53%
LONG-TERM LIABILITIES
Long-Term Debt	$2.632B	$2.635B	$2.635B
YoY Change	-0.3%	-0.53%	-0.53%
Other Long-Term Liabilities	$6.053B	$6.200B	$6.200B
YoY Change	26.61%	55.58%	55.58%
Total Long-Term Liabilities	$8.685B	$8.835B	$8.835B
YoY Change	17.03%	33.18%	33.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$545.0M	$689.0M	$689.0M
Total Long-Term Liabilities	$8.685B	$8.835B	$8.835B
Total Liabilities	$305.6B	$301.9B	$302.6B
YoY Change	-10.73%	-17.15%	-17.11%
SHAREHOLDERS EQUITY
Retained Earnings	$6.403B	$8.283B
YoY Change	33.9%	194.87%
Common Stock	$1.000M	$1.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$510.0M	$443.0M
YoY Change	45.3%	109.95%
Treasury Stock Shares	13.43M shares	11.78M shares
Shareholders Equity	$8.638B	$8.423B	$8.423B
YoY Change
Total Liabilities & Shareholders Equity	$315.0B	$311.1B	$311.1B
YoY Change	-10.68%	-17.16%	-17.16%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$6.186B	-$710.0M	$5.697B
YoY Change	205.48%	-221.31%	78.98%
Depreciation, Depletion And Amortization	$1.226B		-$1.743B
YoY Change	40766.67%		-15945.45%
Cash From Operating Activities	$5.206B	$2.265B	$5.206B
YoY Change	505.35%	4.55%	-9.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$282.0M	-$3.843B	$343.0M
YoY Change	-1009.68%	100.15%	-38.09%
Cash From Investing Activities	-$2.882B	-$3.843B	-$1.374B
YoY Change	1326.73%	100.15%	6.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$321.0M
YoY Change			52.13%
Debt Paid & Issued, Net	$0.00		$0.00
YoY Change
Cash From Financing Activities	-$1.099B	538.0M	-$2.162B
YoY Change	80.46%	-652.36%	-43.62%
NET CHANGE
Cash From Operating Activities	$5.206B	2.265B	$5.206B
Cash From Investing Activities	-$2.882B	-3.843B	-$1.374B
Cash From Financing Activities	-$1.099B	538.0M	-$2.162B
Net Change In Cash	-$2.520B	-1.040B	$1.670B
YoY Change	-5242.86%	-798.46%	172.88%
FREE CASH FLOW
Cash From Operating Activities	$5.206B	$2.265B	$5.206B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001822993
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40274
CY2022	dei	Entity Registrant Name EntityRegistrantName	Jackson Financial Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0486152
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Corporate Way
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Lansing
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48951
CY2022	dei	City Area Code CityAreaCode	517
CY2022	dei	Local Phone Number LocalPhoneNumber	381-5500
CY2022	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.01 Per Share
CY2022	dei	Trading Symbol TradingSymbol	JXN
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1900000000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82281061	shares
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	Chicago, IL
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	48798000000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	49378000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	42489000000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	51547000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	2173000000	usd
CY2021Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	1711000000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	100000000	usd
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	117000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	393000000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	279000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	10967000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	11482000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2021Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	0	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3419000000	usd
CY2021Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3467000000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1417000000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	3595000000	usd
CY2021Q4	us-gaap	Other Investments OtherInvestments	3199000000	usd
CY2022Q4	us-gaap	Investments Investments	65946000000	usd
CY2021Q4	us-gaap	Investments Investments	74227000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2623000000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	514000000	usd
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	503000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13422000000	usd
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14249000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	12000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29641000000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	33126000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	385000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	954000000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	946000000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	928000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	248949000000	usd
CY2022Q4	us-gaap	Assets Assets	311058000000	usd
CY2021Q4	us-gaap	Assets Assets	375559000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	14273000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	18667000000	usd
CY2022Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58195000000	usd
CY2021Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58726000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3582000000	usd
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3639000000	usd
CY2022Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22957000000	usd
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	29007000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2649000000	usd
CY2022Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1048000000	usd
CY2021Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1589000000	usd
CY2022Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	689000000	usd
CY2021Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	913000000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41000000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1732000000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1404000000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	2403000000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	2540000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	195906000000	usd
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	248949000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	301903000000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	364485000000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6063000000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6051000000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	11784813	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5778649	shares
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	443000000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	211000000	usd
CY2022Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	-650000000	usd
CY2021Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	194000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5481000000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1744000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8283000000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2809000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8423000000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10394000000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	732000000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	680000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9155000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11074000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	311058000000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	375559000000	usd
CY2022	us-gaap-supplement	Fee Income FeeIncome	7722000000	usd
CY2021	us-gaap-supplement	Fee Income FeeIncome	8059000000	usd
CY2020	us-gaap-supplement	Fee Income FeeIncome	6928000000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	132000000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	148000000	usd
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	187000000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	2761000000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	3424000000	usd
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2818000000	usd
CY2022	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	3851000000	usd
CY2021	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2478000000	usd
CY2020	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-6451000000	usd
CY2022	us-gaap	Other Income OtherIncome	85000000	usd
CY2021	us-gaap	Other Income OtherIncome	94000000	usd
CY2020	us-gaap	Other Income OtherIncome	64000000	usd
CY2022	us-gaap	Revenues Revenues	14551000000	usd
CY2021	us-gaap	Revenues Revenues	9247000000	usd
CY2020	us-gaap	Revenues Revenues	3546000000	usd
CY2022	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	2290000000	usd
CY2021	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	970000000	usd
CY2020	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	1362000000	usd
CY2022	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	862000000	usd
CY2021	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	834000000	usd
CY2020	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	1301000000	usd
CY2022	us-gaap	Interest Expense InterestExpense	113000000	usd
CY2021	us-gaap	Interest Expense InterestExpense	37000000	usd
CY2020	us-gaap	Interest Expense InterestExpense	88000000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2432000000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2839000000	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1299000000	usd
CY2022	jxn	Cost Of Reinsurance CostOfReinsurance	0	usd
CY2021	jxn	Cost Of Reinsurance CostOfReinsurance	0	usd
CY2020	jxn	Cost Of Reinsurance CostOfReinsurance	2520000000	usd
CY2022	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	1743000000	usd
CY2021	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	520000000	usd
CY2020	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	-533000000	usd
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	7440000000	usd
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	5200000000	usd
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	6037000000	usd
CY2022	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	7111000000	usd
CY2021	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	4047000000	usd
CY2020	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-2491000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1371000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	5740000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43000000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	262000000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5697000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3183000000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1634000000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	66.62
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	33.86
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	64.23
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	33.69
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.14
CY2022	us-gaap	Profit Loss ProfitLoss	5740000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-843000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-573000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	414000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7223000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2080000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1419000000	usd
CY2022	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	-1000000	usd
CY2021	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	1000000	usd
CY2020	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	1000000	usd
CY2022	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	-2000000	usd
CY2021	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	3000000	usd
CY2020	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	4000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7225000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1423000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1485000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1368000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-214000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	43000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	262000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1528000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1106000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-211000000	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7322000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1423000000	usd
CY2020	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	13000000	usd
CY2020	jxn	Stock Issued During Period Value Issued For Debt Restructure StockIssuedDuringPeriodValueIssuedForDebtRestructure	2350000000	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	500000000	usd
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18000000	usd
CY2020	jxn	Stock Distributed During Period Value StockDistributedDuringPeriodValue	18000000	usd
CY2020	jxn	Equity Compensation Reserve Period Increase Decrease EquityCompensationReservePeriodIncreaseDecrease	8000000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9923000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000000	usd
CY2021	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-76000000	usd
CY2021	us-gaap	Dividends Dividends	50000000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	211000000	usd
CY2021	jxn	Stock Issued During Period Value Demerger StockIssuedDuringPeriodValueDemerger	5000000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	123000000	usd
CY2021	jxn	Equity Compensation Reserve Period Increase Decrease EquityCompensationReservePeriodIncreaseDecrease	-8000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11074000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	5740000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7225000000	usd
CY2022	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	9000000	usd
CY2022	us-gaap	Dividends Dividends	199000000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	321000000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9155000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	5740000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-359000000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	182000000	usd
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	377000000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2024000000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2639000000	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-7268000000	usd
CY2022	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	2186000000	usd
CY2021	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-21000000	usd
CY2020	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	440000000	usd
CY2022	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	862000000	usd
CY2021	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	834000000	usd
CY2020	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	1304000000	usd
CY2022	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	530000000	usd
CY2021	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	553000000	usd
CY2020	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	593000000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-11000000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-49000000	usd
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-55000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1413000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	675000000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-776000000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	131000000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	129000000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	56000000	usd
CY2022	jxn	Cash Paid To Received From Reinsurance Transaction CashPaidToReceivedFromReinsuranceTransaction	0	usd
CY2021	jxn	Cash Paid To Received From Reinsurance Transaction CashPaidToReceivedFromReinsuranceTransaction	0	usd
CY2020	jxn	Cash Paid To Received From Reinsurance Transaction CashPaidToReceivedFromReinsuranceTransaction	32000000	usd
CY2022	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	11000000	usd
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-55000000	usd
CY2020	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-36000000	usd
CY2022	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-1119000000	usd
CY2021	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	270000000	usd
CY2020	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	1503000000	usd
CY2022	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	402000000	usd
CY2021	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	757000000	usd
CY2020	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-792000000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-724000000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	403000000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	441000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5206000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5682000000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3712000000	usd
CY2022	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	11535000000	usd
CY2021	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	19568000000	usd
CY2020	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	30094000000	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	84000000	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	50000000	usd
CY2020	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	45000000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1695000000	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1747000000	usd
CY2020	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1201000000	usd
CY2022	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	11606000000	usd
CY2021	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	14733000000	usd
CY2020	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	28400000000	usd
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	249000000	usd
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	111000000	usd
CY2020	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	97000000	usd
CY2022	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1816000000	usd
CY2021	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	2427000000	usd
CY2020	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	2189000000	usd
CY2022	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	674000000	usd
CY2021	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	4836000000	usd
CY2020	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	5321000000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	343000000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	554000000	usd
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-334000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1374000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1296000000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4333000000	usd
CY2022	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	18456000000	usd
CY2021	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	20134000000	usd
CY2020	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	19607000000	usd
CY2022	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	25173000000	usd
CY2021	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	28712000000	usd
CY2020	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	23083000000	usd
CY2022	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	5685000000	usd
CY2021	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2664000000	usd
CY2020	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2561000000	usd
CY2022	jxn	Proceeds From Payments On Repurchase Agreements And Securities Lending ProceedsFromPaymentsOnRepurchaseAgreementsAndSecuritiesLending	-541000000	usd
CY2021	jxn	Proceeds From Payments On Repurchase Agreements And Securities Lending ProceedsFromPaymentsOnRepurchaseAgreementsAndSecuritiesLending	476000000	usd
CY2020	jxn	Proceeds From Payments On Repurchase Agreements And Securities Lending ProceedsFromPaymentsOnRepurchaseAgreementsAndSecuritiesLending	1100000000	usd
CY2022	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	0	usd
CY2021	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	380000000	usd
CY2020	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	-80000000	usd
CY2022	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-825000000	usd
CY2021	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	735000000	usd
CY2020	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-60000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	750000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1593000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7000000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	28000000	usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	0	usd
CY2021	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	5000000	usd
CY2020	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	0	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	186000000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	50000000	usd
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	321000000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	211000000	usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2162000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3774000000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	705000000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1670000000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	612000000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	84000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1935000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-403000000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	107000000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	30000000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	81000000	usd
CY2022	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	506000000	usd
CY2021	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	370000000	usd
CY2020	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	418000000	usd
CY2022	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	112000000	usd
CY2021	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	99000000	usd
CY2020	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	4000000	usd
CY2022Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	13000000	usd
CY2021Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	0	usd
CY2020Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	0	usd
CY2022	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	0	usd
CY2021	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	0	usd
CY2020	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	2350000000	usd
CY2022	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	0	usd
CY2021	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	0	usd
CY2020	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	2350000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2623000000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2019000000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	3000000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	8000000	usd
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	usd
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	104960.3836276
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain amounts in the 2021 Notes to Consolidated Financial Statements have been reclassified to conform to the 2022 presentation.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Consolidated Financial Statements in conformity with GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in the notes, include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assessments as to whether certain entities are variable interest entities, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions impacting estimated future gross profits, including policyholder behavior, mortality rates, expenses, projected hedging costs, investment returns and policy crediting rates, used in the calculation of amortization of deferred acquisition costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions used in calculating policy reserves and liabilities, including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions used in calculating the value of guaranteed benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors deemed appropriate. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the Consolidated Financial Statements in the periods the estimates are changed.</span></div>
CY2022	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Revision of Prior Period Financial Statements</span></div><div><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the Company identified errors related to the classification of certain balances and amounts in the line items of the Consolidated Balance Sheets and Consolidated Income Statements. These errors resulted in the revision of balances and amounts related to deferred sales inducement assets, liabilities for certain life-contingent annuities, sub-advisor fee expenses, and other operating expense items that impacted previously issued Consolidated Financial Statements. The impact of these errors to the current and the prior periods' Consolidated Financial Statements were not considered to be material and had no impact on shareholders' equity or net income. However, to improve the consistency and comparability of the financial statements, management revised the financial statements and related disclosures in this Form 10-K. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Note 24 to the Notes to Consolidated Financial Statements for details of the revisions.</span></div>
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022	us-gaap	Revenues Revenues	14551000000	usd
CY2021	us-gaap	Revenues Revenues	9247000000	usd
CY2020	us-gaap	Revenues Revenues	3546000000	usd
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	7440000000	usd
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	5200000000	usd
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	6037000000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	7068000000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	3785000000	usd
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2488000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1371000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5697000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3183000000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1634000000	usd
CY2022Q4	us-gaap	Assets Assets	311058000000	usd
CY2021Q4	us-gaap	Assets Assets	375559000000	usd
CY2022Q4	jxn	Debt Securities Rated DebtSecuritiesRated	32000000	usd
CY2021Q4	jxn	Debt Securities Rated DebtSecuritiesRated	13000000	usd
CY2022Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2021Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2022Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51071000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	23000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	115000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6401000000	usd
CY2022Q4	us-gaap	Debt Securities DebtSecurities	44762000000	usd
CY2021Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51206000000	usd
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	9000000	usd
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2790000000	usd
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	612000000	usd
CY2021Q4	us-gaap	Debt Securities DebtSecurities	53375000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOne	2472000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	7000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date Year One DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateYearOne	2465000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	9761000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	3000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	15000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	435000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	9338000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	13477000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	11000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	26000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	1541000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	11951000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	9165000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	3000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	46000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	1658000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	7550000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	7732000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	0	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	1000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	2014000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	5719000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51071000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	23000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	115000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6401000000	usd
CY2022Q4	us-gaap	Debt Securities DebtSecurities	44762000000	usd
CY2022Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	90000000	usd
CY2021Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	117000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3571000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	30605000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	3786	security
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	246000000	usd
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	11135000000	usd
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	1344	security
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2830000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	8508000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	1056	security
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	366000000	usd
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	4006000000	usd
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	104	security
CY2022Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	6401000000	usd
CY2022Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	39113000000	usd
CY2022Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	4645	security
CY2021Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	612000000	usd
CY2021Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	15141000000	usd
CY2021Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	1421	security
CY2022	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivable
CY2021	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivable
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	54000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-18000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	5000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	17000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	14000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	2000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	9000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2021	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2021	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	16000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	0	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	407000000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	381000000	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	100000000	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	126000000	usd
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	138000000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	2761000000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	3424000000	usd
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2818000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	41000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	169000000	usd
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	778000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	429000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	88000000	usd
CY2020	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	196000000	usd
CY2022	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	5000000	usd
CY2021	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	10000000	usd
CY2020	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	14000000	usd
CY2022	jxn	Debt Securities Available For Sale Gross Impairments DebtSecuritiesAvailableForSaleGrossImpairments	0	usd
CY2021	jxn	Debt Securities Available For Sale Gross Impairments DebtSecuritiesAvailableForSaleGrossImpairments	0	usd
CY2020	jxn	Debt Securities Available For Sale Gross Impairments DebtSecuritiesAvailableForSaleGrossImpairments	27000000	usd
CY2022	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	16000000	usd
CY2021	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	-62000000	usd
CY2020	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	61000000	usd
CY2022	jxn	Other Operating Gain Loss OtherOperatingGainLoss	50000000	usd
CY2021	jxn	Other Operating Gain Loss OtherOperatingGainLoss	49000000	usd
CY2020	jxn	Other Operating Gain Loss OtherOperatingGainLoss	-103000000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-359000000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	182000000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	377000000	usd
CY2022	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	3851000000	usd
CY2021	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2478000000	usd
CY2020	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-6451000000	usd
CY2022	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	5376000000	usd
CY2021	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	2604000000	usd
CY2020	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	7612000000	usd
CY2022	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.93
CY2021	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.95
CY2020	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.97
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	7980000000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	9600000000	usd
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	25533000000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	276000000	usd
CY2022Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	3285000000	usd
CY2021Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	3860000000	usd
CY2022	jxn	Interest And Principal Payment Deferral Repayment Period Covid19 InterestAndPrincipalPaymentDeferralRepaymentPeriodCOVID19	P1Y
CY2022Q4	jxn	Deferred Interest And Principal Payment Amount Covid19 DeferredInterestAndPrincipalPaymentAmountCOVID19	10000000	usd
CY2022	jxn	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Consolidated Balance Sheets
CY2021	jxn	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Consolidated Balance Sheets
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	179000000	usd
CY2021	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2021	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-85000000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	48000000	usd
CY2021Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	44000000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15000000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	16000000	usd
CY2022	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	18000000	usd
CY2022	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	usd
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	6000000	usd
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	7000000	usd
CY2021	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	2000000	usd
CY2021	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1315000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1927000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1260000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1554000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1511000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	3978000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11549000000	usd
CY2022Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1887000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1447000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1671000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1691000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1420000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	3362000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11482000000	usd
CY2021Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2022Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	15000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11549000000	usd
CY2021Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2021Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	6000000	usd
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11482000000	usd
CY2022Q4	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	3000000	usd
CY2021Q4	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	0	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3400000000	usd
CY2021Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3500000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1000000000.0	usd
CY2021Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1000000000.0	usd
CY2021Q2	jxn	Investment In Limited Partnership InvestmentInLimitedPartnership	420000000	usd
CY2021Q2	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	236000000	usd
CY2021Q3	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	168000000	usd
CY2022Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	35000000	usd
CY2021Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	17000000	usd
CY2022Q4	jxn	Securities Loaned Minimum Fair Value Collateral Percent SecuritiesLoanedMinimumFairValueCollateralPercent	1.02
CY2022Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	36000000	usd
CY2021Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	17000000	usd
CY2022Q4	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0254
CY2021Q4	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0007
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1012000000	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1572000000	usd
CY2022	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	1012000000	usd
CY2021	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	2349000000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	5395000000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1875000000	usd
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-8323000000	usd
CY2022Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	885000000	usd
CY2021Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	1376000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	858000000	usd
CY2021Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	1576000000	usd
CY2022Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	1680000000	usd
CY2021Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	0	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	1650000000	usd
CY2021Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	0	usd
CY2022Q4	jxn	Derivative Disbursement Obligation DerivativeDisbursementObligation	30000000	usd
CY2021Q4	jxn	Derivative Disbursement Obligation DerivativeDisbursementObligation	200000000	usd
CY2022Q4	jxn	Derivative Claim DerivativeClaim	27000000	usd
CY2021Q4	jxn	Derivative Claim DerivativeClaim	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1270000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2022Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	683000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	157000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	45000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	2065000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2022Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1638000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	42000000	usd
CY2022Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3113000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3113000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	36000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	2650000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	42000000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1417000000	usd
CY2021Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1417000000	usd
CY2021Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	41000000	usd
CY2021Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	817000000	usd
CY2021Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	555000000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	4000000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	41000000	usd
CY2021Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41000000	usd
CY2021Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	41000000	usd
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	usd
CY2021Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	17000000	usd
CY2021Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2021Q4	us-gaap	Securities Loaned SecuritiesLoaned	17000000	usd
CY2021Q4	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2021Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	17000000	usd
CY2021Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2021Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1572000000	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1572000000	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1572000000	usd
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	1630000000	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	1630000000	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	41000000	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	17000000	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	1572000000	usd
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	393000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2022Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	440000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3419000000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4298000000	usd
CY2022Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	170000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	251240000000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	-1018000000	usd
CY2022Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	424000000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1732000000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3203000000	usd
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	2772000000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	279000000	usd
CY2021Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	413000000	usd
CY2021Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3467000000	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1417000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2623000000	usd
CY2021Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	262000000	usd
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	248949000000	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	310785000000	usd
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	4071000000	usd
CY2021Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	3759000000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41000000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1404000000	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	9275000000	usd
CY2021Q4	us-gaap	Alternative Investment AlternativeInvestment	2418000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	699000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	68000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	215000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	292000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	554000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	68000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	55000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	261000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	246000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	28000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	5000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	53000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	9000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	59000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	27000000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2022Q4	jxn	Federal Home Loan Bank Capital Stock Share Price FederalHomeLoanBankCapitalStockSharePrice	100
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10967000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	958000000	usd
CY2022Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	146000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	36221000000	usd
CY2022Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1128000000	usd
CY2022Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5887000000	usd
CY2022Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	2004000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	22533000000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2635000000	usd
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned	36000000	usd
CY2022Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1012000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	195906000000	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	11482000000	usd
CY2021Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	1008000000	usd
CY2021Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	125000000	usd
CY2021Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	36318000000	usd
CY2021Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	894000000	usd
CY2020	us-gaap	Deferred Policy Acquisition Costs Impairment Loss DeferredPolicyAcquisitionCostsImpairmentLoss	626000000	usd
CY2021Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5986000000	usd
CY2021Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	1950000000	usd
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	24533000000	usd
CY2021Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2649000000	usd
CY2021Q4	us-gaap	Securities Loaned SecuritiesLoaned	17000000	usd
CY2021Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1572000000	usd
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	248949000000	usd
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option Alternative Investments FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOptionAlternativeInvestments	715000000	usd
CY2022	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	Deferred Acquisition Costs and Deferred Sales Inducements<div style="padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Acquisition Costs</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current accounting guidance, certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred acquisition costs ("DAC"). These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DAC are increased by interest thereon and amortized into income in proportion to anticipated premium revenues for traditional life policies and in proportion to estimated gross profits, including net gains (losses) on derivatives and investments, for annuities and interest-sensitive life products. Due to volatility of certain factors that affect gross profits, including net gains (losses) on derivatives and investments, amortization may be a benefit or a charge in any given period. In the event of negative amortization, the related DAC balance is capped at the initial amount capitalized, plus interest. Unamortized DAC are written off when a contract is internally replaced and substantially changed. DAC is reviewed periodically to ensure that the unamortized portion does not exceed the expected recoverable amounts. The Company’s accounting policy includes reinsurance balances when evaluating recoverability of DAC. Any amount deemed unrecoverable is written off with a charge through DAC amortization. Other than the amounts related to the Athene Reinsurance Transaction in 2020 noted below, no such write-offs were required for 2022 and 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As available-for-sale debt securities are carried at fair value, an adjustment is made to DAC equal to the change in amortization that would have occurred if such securities had been sold at their stated fair value and the proceeds reinvested at current yields. This adjustment, along with the change in net unrealized gains (losses) on available-for-sale debt securities, net of applicable tax, is credited or charged directly to equity as a component of other comprehensive income. At December 31, 2022 and 2021, DAC increased by $229 million and decreased by $63 million, respectively, to reflect this adjustment.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For variable annuity business, the Company employs a mean reversion methodology that is applied with the objective of adjusting the amortization of DAC that would otherwise be highly volatile due to fluctuations in the level of future gross profits arising from changes in equity market levels. The mean reversion methodology achieves this objective by applying a dynamic adjustment to the assumption for short-term future investment returns. Under this methodology, the projected returns for the next five years are set such that, when combined with the actual returns for the current and preceding two years, the average rate of return over the eight-year period is 7.15% for 2022 and 2021, after external investment management fees. The mean reversion methodology does, however, include a cap and a floor of 15% and 0% per annum, respectively, on the projected return for each of the next five years. At December 31, 2022 and 2021, projected returns under mean reversion were within the range bound by the 15% cap and 0% floor. At both December 31, 2022 and 2021, projected returns after the next five years were set at 7.15%.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the recoverability of previously established DAC assets in accordance with ASC 944-30-35-22. The Company determined it was appropriate to immediately write-off the remaining DAC on the business reinsured to Athene as no future profits will be recognized on this business at this aggregated level of recoverability testing. Accordingly, amortization of DAC for the year ended December 31, 2020 included a write-off of $626 million, related to the blocks of fixed and fixed-index annuity business, as a result of the Athene Reinsurance Transaction (see Note 8 to Consolidated Financial Statements for a description of the Athene Reinsurance Transaction).</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of, and changes, in deferred acquisition costs were as follows (in millions):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"/><td style="width:52.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,249</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,897</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,337</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">624</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">790</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">738</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,743)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(520)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">533</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized investment (gains) losses </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">292</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">82</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">289</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,422</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,249</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,897</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Actuarial Assumption Changes (Unlocking)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:0.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annually, or as circumstances warrant, the Company conducts a comprehensive review of the assumptions used for its estimates of future gross profits underlying the amortization of DAC and deferred sales inducements ("DSI"), as well as the valuation of the embedded derivatives and reserves for life insurance and annuity products with living benefit and death benefit guarantees. These assumptions include, but may not be limited to, policyholder behavior, mortality rates, expenses, projected hedging costs, investment returns and policy crediting rates. Based on this review, the cumulative balances of DAC, DSI and life and annuity guaranteed benefit reserves are adjusted with a corresponding benefit or charge to net income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Sales Inducements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain sales inducement costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as DSI. Bonus interest on deferred fixed annuities and contract enhancements on fixed index annuities and variable annuities are capitalized as DSI and included in other assets. DSI are increased by interest thereon and amortized into income in proportion to estimated gross profits, including net gains (losses) on derivatives and investments. DSI are reviewed periodically to ensure that the unamortized portion does not exceed the expected recoverable amounts. Any amount deemed unrecoverable is written off with a charge through DSI amortization. Other than the amounts related to the Athene Reinsurance Transaction in 2020 noted below, no such write-offs were required for 2022, 2021, and 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the recoverability of previously established DAC and DSI assets in accordance with ASC 944-30-35-22. The Company determined it was appropriate to immediately write-off the remaining DAC and DSI costs on the business reinsured to Athene as no future profits will be recognized on this business at this aggregated level of recoverability testing. Accordingly, amortization of DSI costs for the year ended December 31, 2020, included a write-off of $138 million, related to the blocks of fixed and fixed-index annuity business, as a result of the Athene Reinsurance Transaction.</span></div><div><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of and changes in deferred sales inducements, which are reported in other assets, were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"/><td style="width:52.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">140</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of sales inducements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(152)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized investment losses (gains)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">88</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, end of year</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77</span></td></tr></table></div>
CY2022	us-gaap	Deferred Policy Acquisition Costs Period Increase Decrease DeferredPolicyAcquisitionCostsPeriodIncreaseDecrease	229000000	usd
CY2021	us-gaap	Deferred Policy Acquisition Costs Period Increase Decrease DeferredPolicyAcquisitionCostsPeriodIncreaseDecrease	-63000000	usd
CY2022	jxn	Short Term Investment Expected Return Over Eight Year Period ShortTermInvestmentExpectedReturnOverEightYearPeriod	0.0715
CY2021	jxn	Short Term Investment Expected Return Cap ShortTermInvestmentExpectedReturnCap	0.15
CY2021	jxn	Short Term Investment Expected Return Floor ShortTermInvestmentExpectedReturnFloor	0
CY2022	jxn	Short Term Investment Expected Return Cap ShortTermInvestmentExpectedReturnCap	0.15
CY2022	jxn	Short Term Investment Expected Return Floor ShortTermInvestmentExpectedReturnFloor	0
CY2022	jxn	Short Term Investment Expected Return Over Five Year Period ShortTermInvestmentExpectedReturnOverFiveYearPeriod	0.0715
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14249000000	usd
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13897000000	usd
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12337000000	usd
CY2022	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	624000000	usd
CY2021	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	790000000	usd
CY2020	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	738000000	usd
CY2022	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	-1743000000	usd
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	-520000000	usd
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	533000000	usd
CY2022	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-292000000	usd
CY2021	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-82000000	usd
CY2020	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-289000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13422000000	usd
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14249000000	usd
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13897000000	usd
CY2020	us-gaap	Deferred Sales Inducement Cost Impairment Loss DeferredSalesInducementCostImpairmentLoss	138000000	usd
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	77000000	usd
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	77000000	usd
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	140000000	usd
CY2022	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	4000000	usd
CY2021	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	2000000	usd
CY2020	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	1000000	usd
CY2022	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	4000000	usd
CY2021	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	3000000	usd
CY2020	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	152000000	usd
CY2022	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	-2000000	usd
CY2021	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	-1000000	usd
CY2020	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	-88000000	usd
CY2022Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	79000000	usd
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	77000000	usd
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	77000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	12000000	usd
CY2020	jxn	Reinsurance Agreement Ceding Commission ReinsuranceAgreementCedingCommission	1202000000	usd
CY2020	us-gaap	Reinsurance Loss On Uncollectible Accounts In Period Amount ReinsuranceLossOnUncollectibleAccountsInPeriodAmount	2520000000	usd
CY2020	jxn	Write Off Of Deferred Acquisition Costs And Deferred Sales Inducements WriteOffOfDeferredAcquisitionCostsAndDeferredSalesInducements	764000000	usd
CY2020	jxn	Pre Tax Gain Loss On Coinsurance Agreement Transaction PreTaxGainLossOnCoinsuranceAgreementTransaction	2082000000	usd
CY2020	jxn	Reinsurance Assets Written Off ReinsuranceAssetsWrittenOff	30100000000	usd
CY2020	jxn	Reinsurance Ceded Reserves ReinsuranceCededReserves	27600000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	23226000000	usd
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	28892000000	usd
CY2022Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22957000000	usd
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	29007000000	usd
CY2022	us-gaap	Direct Premiums Earned DirectPremiumsEarned	360000000	usd
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	407000000	usd
CY2020	us-gaap	Direct Premiums Earned DirectPremiumsEarned	336000000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	40000000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	42000000	usd
CY2020	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	47000000	usd
CY2022	us-gaap	Ceded Premiums Earned CededPremiumsEarned	268000000	usd
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	301000000	usd
CY2020	us-gaap	Ceded Premiums Earned CededPremiumsEarned	196000000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	132000000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	148000000	usd
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	187000000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1692000000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1488000000	usd
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1611000000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	866000000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	876000000	usd
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	749000000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	922000000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	863000000	usd
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	666000000	usd
CY2022	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	-654000000	usd
CY2021	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	531000000	usd
CY2020	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	332000000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2290000000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	970000000	usd
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1362000000	usd
CY2022Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	820000000	usd
CY2021Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	863000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29641000000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	33126000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits Life LiabilityForFuturePolicyBenefitsLife	3951000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits Life LiabilityForFuturePolicyBenefitsLife	4262000000	usd
CY2022Q4	us-gaap	Guaranteed Interest Contracts GuaranteedInterestContracts	1779000000	usd
CY2021Q4	us-gaap	Guaranteed Interest Contracts GuaranteedInterestContracts	5477000000	usd
CY2022Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1033000000	usd
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1050000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits Disability And Accident Benefits LiabilityForFuturePolicyBenefitsDisabilityAndAccidentBenefits	1164000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits Disability And Accident Benefits LiabilityForFuturePolicyBenefitsDisabilityAndAccidentBenefits	1204000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits Individual And Group Annuities And Supplementary Contracts LiabilityForFuturePolicyBenefitsIndividualAndGroupAnnuitiesAndSupplementaryContracts	4586000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits Individual And Group Annuities And Supplementary Contracts LiabilityForFuturePolicyBenefitsIndividualAndGroupAnnuitiesAndSupplementaryContracts	4895000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	1158000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	1152000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits Other Contracts LiabilityForFuturePolicyBenefitsOtherContracts	602000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits Other Contracts LiabilityForFuturePolicyBenefitsOtherContracts	627000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	14273000000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	18667000000	usd
CY2022Q4	jxn	Annuity Account Values AnnuityAccountValues	13179000000	usd
CY2022Q4	us-gaap	Ceded Premiums Payable CededPremiumsPayable	21849000000	usd
CY2022Q4	jxn	Annuity Account Values And Ceded Premiums Payable AnnuityAccountValuesAndCededPremiumsPayable	35028000000	usd
CY2021Q4	jxn	Annuity Account Values AnnuityAccountValues	12188000000	usd
CY2021Q4	us-gaap	Ceded Premiums Payable CededPremiumsPayable	24956000000	usd
CY2021Q4	jxn	Annuity Account Values And Ceded Premiums Payable AnnuityAccountValuesAndCededPremiumsPayable	37144000000	usd
CY2022Q4	jxn	Account Value Interest Sensitive Life Insurance AccountValueInterestSensitiveLifeInsurance	7050000000	usd
CY2021Q4	jxn	Account Value Interest Sensitive Life Insurance AccountValueInterestSensitiveLifeInsurance	7331000000	usd
CY2022Q4	jxn	Retro Treaties Account Value RetroTreatiesAccountValue	4147000000	usd
CY2021Q4	jxn	Retro Treaties Account Value RetroTreatiesAccountValue	4222000000	usd
CY2022Q4	jxn	Interest Sensitive Life Insurance And Retro Treaties Account Values InterestSensitiveLifeInsuranceAndRetroTreatiesAccountValues	11197000000	usd
CY2021Q4	jxn	Interest Sensitive Life Insurance And Retro Treaties Account Values InterestSensitiveLifeInsuranceAndRetroTreatiesAccountValues	11553000000	usd
CY2022Q4	jxn	Funding Agreement FundingAgreement	2100000000	usd
CY2021Q4	jxn	Funding Agreement FundingAgreement	2000000000.0	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	196000000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	196000000000	usd
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	249000000000	usd
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	249000000000	usd
CY2022	jxn	Net Amount At Risk By Product And Guarantee Compound Interest Rate Based On Simple Interest Rate Of Five Percent NetAmountAtRiskByProductAndGuaranteeCompoundInterestRateBasedOnSimpleInterestRateOfFivePercent	0.041
CY2022	jxn	Net Amount At Risk By Product And Guarantee Compound Interest Rate Based On Simple Interest Rate Of Eight Percent NetAmountAtRiskByProductAndGuaranteeCompoundInterestRateBasedOnSimpleInterestRateOfEightPercent	0.060
CY2022	jxn	Net Amount At Risk By Product And Guarantee Compound Interest Rate Period NetAmountAtRiskByProductAndGuaranteeCompoundInterestRatePeriod	P10Y
CY2022Q4	us-gaap	Schedule Of Fair Value Of Separate Accounts By Major Category Of Investment Fair Value ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentFairValue	171841000000	usd
CY2021Q4	us-gaap	Schedule Of Fair Value Of Separate Accounts By Major Category Of Investment Fair Value ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentFairValue	219324000000	usd
CY2021Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1370000000	usd
CY2021Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	usd
CY2020Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1418000000	usd
CY2022	us-gaap	Liabilities For Guarantees On Long Duration Contracts Incurred Benefits1 LiabilitiesForGuaranteesOnLongDurationContractsIncurredBenefits1	1058000000	usd
CY2021	us-gaap	Liabilities For Guarantees On Long Duration Contracts Incurred Benefits1 LiabilitiesForGuaranteesOnLongDurationContractsIncurredBenefits1	55000000	usd
CY2022	us-gaap	Liabilities For Guarantees On Long Duration Contracts Payment For Benefits LiabilitiesForGuaranteesOnLongDurationContractsPaymentForBenefits	219000000	usd
CY2021	us-gaap	Liabilities For Guarantees On Long Duration Contracts Payment For Benefits LiabilitiesForGuaranteesOnLongDurationContractsPaymentForBenefits	103000000	usd
CY2022Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	2209000000	usd
CY2021Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1370000000	usd
CY2022Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitReserveLiability	-2154000000	usd
CY2021Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitReserveLiability	2626000000	usd
CY2022Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit With Guaranteed Payments Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitWithGuaranteedPaymentsReserveLiability	441000000	usd
CY2021Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit With Guaranteed Payments Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitWithGuaranteedPaymentsReserveLiability	196000000	usd
CY2022Q4	jxn	Long Duration Contracts Lifetime Income Rider Liability LongDurationContractsLifetimeIncomeRiderLiability	58000000	usd
CY2021Q4	jxn	Long Duration Contracts Lifetime Income Rider Liability LongDurationContractsLifetimeIncomeRiderLiability	37000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2649000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	598000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q4	jxn	Long Term Debt Maturity Year Five And Thereafter LongTermDebtMaturityYearFiveAndThereafter	2037000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2021Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2400000000	usd
CY2022Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	96000000	usd
CY2021Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	95000000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-43000000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-71000000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-80000000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2000000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-42000000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-73000000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-78000000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1358000000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	653000000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-703000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	55000000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22000000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-73000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1413000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	675000000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-776000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1371000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1493000000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	795000000	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-522000000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	44000000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	15000000	usd
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-56000000	usd
CY2022	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	142000000	usd
CY2021	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	146000000	usd
CY2020	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	158000000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2000000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1000000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-16000000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	24000000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	46000000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	61000000	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	usd
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-53000000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2000000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-16000000	usd
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	11000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1371000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.193
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.159
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.343
CY2020	jxn	Effective Income Tax Rate Reconciliation State And Local Income Taxes True Up Of Prior Periods Amount EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesTrueUpOfPriorPeriodsAmount	-33000000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-403000000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000000	usd
CY2022	jxn	Income Tax Paid Refunded Excluding Interest IncomeTaxPaidRefundedExcludingInterest	-314000000	usd
CY2022	jxn	Income Tax Paid Refunded Interest IncomeTaxPaidRefundedInterest	-24000000	usd
CY2022	jxn	Income Tax Paid Refunded Refunds From Overpayment IncomeTaxPaidRefundedRefundsFromOverpayment	-73000000	usd
CY2022Q4	jxn	Deferred Tax Assets Policy Reserves And Other Insurance Items DeferredTaxAssetsPolicyReservesAndOtherInsuranceItems	1837000000	usd
CY2021Q4	jxn	Deferred Tax Assets Policy Reserves And Other Insurance Items DeferredTaxAssetsPolicyReservesAndOtherInsuranceItems	2695000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	165000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	181000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	789000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1128000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	1297000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	587000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	306000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	75000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4750000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4325000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	910000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3840000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4323000000	usd
CY2022Q4	jxn	Deferred Tax Liabilities Deferred Acquisition Costs And Sales Inducements DeferredTaxLiabilitiesDeferredAcquisitionCostsAndSalesInducements	2644000000	usd
CY2021Q4	jxn	Deferred Tax Liabilities Deferred Acquisition Costs And Sales Inducements DeferredTaxLiabilitiesDeferredAcquisitionCostsAndSalesInducements	2873000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	781000000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	23000000	usd
CY2022Q4	jxn	Deferred Tax Liabilities Unrealized Gains On Investments DeferredTaxLiabilitiesUnrealizedGainsOnInvestments	0	usd
CY2021Q4	jxn	Deferred Tax Liabilities Unrealized Gains On Investments DeferredTaxLiabilitiesUnrealizedGainsOnInvestments	453000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	30000000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	20000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3455000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3369000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	385000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	954000000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4000000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2000000	usd
CY2022Q4	jxn	Operating Loss Carryforward Acquisition OperatingLossCarryforwardAcquisition	137000000	usd
CY2021Q4	jxn	Operating Loss Carryforward Acquisition OperatingLossCarryforwardAcquisition	137000000	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	6000000	usd
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	6000000	usd
CY2022Q4	jxn	Operating Loss And Tax Credit Carryforwards OperatingLossAndTaxCreditCarryforwards	3105000000	usd
CY2021Q4	jxn	Operating Loss And Tax Credit Carryforwards OperatingLossAndTaxCreditCarryforwards	1584000000	usd
CY2022Q4	jxn	Operating Loss Carryforwards Section382 Annual Limitation OperatingLossCarryforwardsSection382AnnualLimitation	21000000	usd
CY2022Q4	jxn	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	127000000	usd
CY2022Q4	jxn	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	223000000	usd
CY2022Q4	jxn	Tax Credit Carryforward Period TaxCreditCarryforwardPeriod	P10Y
CY2021	jxn	Unrecognized Tax Benefits Increase Decrease Resulting From Tax Reserves Position UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromTaxReservesPosition	-2000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26000000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36000000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	43000000	usd
CY2022	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	46000000	usd
CY2021	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	33000000	usd
CY2020	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	28000000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	7000000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8000000	usd
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	12000000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	usd
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	5000000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	3000000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	4000000	usd
CY2020	us-gaap	Sublease Income SubleaseIncome	5000000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8000000	usd
CY2021	us-gaap	Lease Cost LeaseCost	8000000	usd
CY2020	us-gaap	Lease Cost LeaseCost	12000000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	9000000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	11000000	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	12000000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	40000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36000000	usd
CY2022	jxn	Share Based Compensation Arrangement By Share Based Payment Award Plan Term ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanTerm	P10Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	11000000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	131000000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	129000000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29000000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	26000000	usd
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12000000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	50000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y25D
CY2022	jxn	Investment Management Fees InvestmentManagementFees	83000000	usd
CY2021	jxn	Investment Management Fees InvestmentManagementFees	104000000	usd
CY2020	jxn	Investment Management Fees InvestmentManagementFees	60000000	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6000000000.0	usd
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6100000000	usd
CY2022	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	3688000000	usd
CY2021	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	136000000	usd
CY2020	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-1933000000	usd
CY2021Q4	jxn	Statutory Basis Value Of Business Acquired StatutoryBasisValueOfBusinessAcquired	33000000	usd
CY2022Q4	jxn	Statutory Basis Value Of Business Acquired StatutoryBasisValueOfBusinessAcquired	0	usd
CY2022	jxn	Defined Contribution Plan Eligibility Number Of Service Hours In Twelve Month Period DefinedContributionPlanEligibilityNumberOfServiceHoursInTwelveMonthPeriod	1000	h
CY2022	jxn	Defined Contribution Plan Requisite Service Period DefinedContributionPlanRequisiteServicePeriod	P12M
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31000000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	32000000	usd
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	34000000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	469000000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	564000000	usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	-47000000	usd
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	54000000	usd
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	56000000	usd
CY2022	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	1010000000	usd
CY2021	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	1126000000	usd
CY2020	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	907000000	usd
CY2022	jxn	Other Commission Expense OtherCommissionExpense	846000000	usd
CY2021	jxn	Other Commission Expense OtherCommissionExpense	1042000000	usd
CY2020	jxn	Other Commission Expense OtherCommissionExpense	1020000000	usd
CY2022	jxn	Sub Advisor Expenses SubAdvisorExpenses	329000000	usd
CY2021	jxn	Sub Advisor Expenses SubAdvisorExpenses	389000000	usd
CY2020	jxn	Sub Advisor Expenses SubAdvisorExpenses	324000000	usd
CY2022	jxn	Ceded Commission Gain Loss CededCommissionGainLoss	0	usd
CY2021	jxn	Ceded Commission Gain Loss CededCommissionGainLoss	0	usd
CY2020	jxn	Ceded Commission Gain Loss CededCommissionGainLoss	1202000000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	875000000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1078000000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	985000000	usd
CY2022	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-628000000	usd
CY2021	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-796000000	usd
CY2020	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-735000000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2432000000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2839000000	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1299000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-8296000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-1829000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	2598000000	usd
CY2022	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	382000000	usd
CY2021	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	90000000	usd
CY2020	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	131000000	usd
CY2022	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	811000000	usd
CY2021	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	375000000	usd
CY2020	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	-602000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-7103000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1364000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	2127000000	usd
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	122000000	usd
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	713000000	usd
CY2020	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	704000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7225000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1423000000	usd
CY2022Q4	jxn	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	104960.3836276
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2021Q4	jxn	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2022Q1	jxn	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94464343	shares
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5778649	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88685694	shares
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1650973	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	7646569	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82690098	shares
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.50
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5697000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3183000000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1634000000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85513787	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93994520	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67658901	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3176913	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	470991	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88690700	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94465511	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67658901	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	66.62
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	33.86
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	64.23
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	33.69
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.14
CY2021	jxn	Reclassification Impacts In Cash Flows ReclassificationImpactsInCashFlows	61000000	usd
CY2020	jxn	Reclassification Impacts In Cash Flows ReclassificationImpactsInCashFlows	65000000	usd
CY2022Q1	us-gaap	Revenues Revenues	4364000000	usd
CY2021Q1	us-gaap	Revenues Revenues	5606000000	usd
CY2022Q2	us-gaap	Revenues Revenues	6546000000	usd
CY2021Q2	us-gaap	Revenues Revenues	341000000	usd
CY2022Q3	us-gaap	Revenues Revenues	4022000000	usd
CY2021Q3	us-gaap	Revenues Revenues	1575000000	usd
CY2022Q4	us-gaap	Revenues Revenues	-381000000	usd
CY2021Q4	us-gaap	Revenues Revenues	1725000000	usd
CY2022Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1978000000	usd
CY2021Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2020000000	usd
CY2022Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2895000000	usd
CY2021Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	879000000	usd
CY2022Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1995000000	usd
CY2021Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1323000000	usd
CY2022Q4	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	572000000	usd
CY2021Q4	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	977000000	usd
CY2022Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	2386000000	usd
CY2021Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	3586000000	usd
CY2022Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	3651000000	usd
CY2021Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-538000000	usd
CY2022Q3	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	2027000000	usd
CY2021Q3	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	252000000	usd
CY2022Q4	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-953000000	usd
CY2021Q4	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	748000000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	330000000	usd
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	586000000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	717000000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	559000000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16000000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-235000000	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	87000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2056000000	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	3000000000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	2934000000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-484000000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	1468000000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	268000000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-718000000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	661000000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31000000	usd
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	68000000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31000000	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	56000000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11000000	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	62000000	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8000000	usd
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	76000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2025000000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2932000000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2903000000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-540000000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1479000000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	206000000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-710000000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	585000000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	23.45
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	31.03
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	33.77
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.72
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	17.38
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.48
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	22.51
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	31.03
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	32.56
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.72
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	16.83
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.18
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.48
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.19
CY2022Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Cost SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost	71475000000	usd
CY2022Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	65946000000	usd
CY2022Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	13000000	usd
CY2021Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	0	usd
CY2020Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	0	usd
CY2022	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	0	usd
CY2021	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	0	usd
CY2020	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	2350000000	usd
CY2022	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	0	usd
CY2021	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	0	usd
CY2020	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	2350000000	usd
CY2022Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	13422000000	usd
CY2022Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	14273000000	usd
CY2022Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	58195000000	usd
CY2021Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	14249000000	usd
CY2021Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	18667000000	usd
CY2021Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	58726000000	usd
CY2020Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	13897000000	usd
CY2020Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	22512000000	usd
CY2020Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	63592000000	usd
CY2022	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	132000000	usd
CY2022	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2761000000	usd
CY2022	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	862000000	usd
CY2022	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	1743000000	usd
CY2022	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2432000000	usd
CY2021	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	148000000	usd
CY2021	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	3424000000	usd
CY2021	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	834000000	usd
CY2021	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	520000000	usd
CY2021	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2839000000	usd
CY2020	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	187000000	usd
CY2020	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2818000000	usd
CY2020	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	1301000000	usd
CY2020	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	-533000000	usd
CY2020	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	1299000000	usd
CY2022Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	86792000000	usd
CY2022Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	49007000000	usd
CY2022Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	15976000000	usd
CY2022Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	53761000000	usd
CY2022Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.297
CY2022	us-gaap	Direct Premiums Earned DirectPremiumsEarned	360000000	usd
CY2022	us-gaap	Ceded Premiums Earned CededPremiumsEarned	268000000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	40000000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	132000000	usd
CY2022	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.303
CY2021Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	105704000000	usd
CY2021Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	63548000000	usd
CY2021Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	16358000000	usd
CY2021Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	58514000000	usd
CY2021Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.280
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	407000000	usd
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	301000000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	42000000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	148000000	usd
CY2021	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.284
CY2020Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	118328000000	usd
CY2020Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	72188000000	usd
CY2020Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	17034000000	usd
CY2020Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	63174000000	usd
CY2020Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.270
CY2020	us-gaap	Direct Premiums Earned DirectPremiumsEarned	336000000	usd
CY2020	us-gaap	Ceded Premiums Earned CededPremiumsEarned	196000000	usd
CY2020	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	47000000	usd
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	187000000	usd
CY2020	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.251
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	117000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	947000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	21000000	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1043000000	usd
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	208000000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	11000000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	102000000	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	117000000	usd

Files In Submission

Name	View Source	Status
jxn-20221231_def.xml	Edgar Link	unprocessable
jxn-20221231_cal.xml	Edgar Link	unprocessable
jxn-20221231_pre.xml	Edgar Link	unprocessable
jxn-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001822993-23-000009-index-headers.html	Edgar Link	pending
0001822993-23-000009-index.html	Edgar Link	pending
0001822993-23-000009.txt	Edgar Link	pending
0001822993-23-000009-xbrl.zip	Edgar Link	pending
exhibit1012pchadmyerslette.htm	Edgar Link	pending
exhibit108jacksonfinancial.htm	Edgar Link	pending
exhibit211listofsubsidiari.htm	Edgar Link	pending
exhibit231auditorsconsent_.htm	Edgar Link	pending
exhibit311fy_202210-k.htm	Edgar Link	pending
exhibit312fy_202210-k.htm	Edgar Link	pending
exhibit321fy_202210-k.htm	Edgar Link	pending
exhibit322fy_202210-k.htm	Edgar Link	pending
exhibit48descriptionofsecu.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_14.jpg	Edgar Link	pending
jxn-20221231.htm	Edgar Link	pending
jxn-20221231.xsd	Edgar Link	pending
jxn-20221231_g1.jpg	Edgar Link	pending
jxn-20221231_g2.jpg	Edgar Link	pending
jxn-20221231_g3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
jxn-20221231_htm.xml	Edgar Link	completed
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R149.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R150.htm	Edgar Link	pending
R151.htm	Edgar Link	pending
R152.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JXN
Jackson Financial Inc. Stock $jxn

2023 Q1 Form 10-K Financial Statement

#000182299323000009 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN Jackson Financial Inc. Stock $jxn

2023 Q1 Form 10-K Financial Statement

#000182299323000009 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN
Jackson Financial Inc. Stock $jxn